| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 51.072 | 59.983 | 53.485 | 33.401 | 36.941 | 46.224 | 53.695 | 57.821 | 69.159 | 61.310 |
| Total Income - EUR | 51.072 | 59.991 | 53.635 | 36.896 | 36.941 | 46.224 | 54.621 | 57.924 | 69.427 | 61.310 |
| Total Expenses - EUR | 43.904 | 50.428 | 49.054 | 36.296 | 35.069 | 41.504 | 39.825 | 43.042 | 53.593 | 47.142 |
| Gross Profit/Loss - EUR | 7.168 | 9.563 | 4.580 | 600 | 1.872 | 4.720 | 14.796 | 14.881 | 15.835 | 14.168 |
| Net Profit/Loss - EUR | 5.500 | 7.768 | 4.043 | 265 | 1.503 | 3.740 | 13.148 | 13.386 | 13.252 | 11.923 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Teobiomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 29 | 0 | 1.195 | 4.567 | 4.386 | 3.325 | 2.311 | 1.404 | 520 | 421 |
| Current Assets | 15.214 | 16.400 | 17.010 | 15.313 | 17.352 | 19.224 | 24.391 | 24.237 | 32.549 | 26.784 |
| Inventories | 15.205 | 14.315 | 16.514 | 15.092 | 17.156 | 18.184 | 14.408 | 14.248 | 15.233 | 15.677 |
| Receivables | 0 | 1.314 | 4 | 105 | 4 | 4 | 0 | 0 | 0 | 652 |
| Cash | 9 | 771 | 492 | 115 | 193 | 1.036 | 9.983 | 9.988 | 17.316 | 10.454 |
| Shareholders Funds | 4.193 | 11.918 | 8.317 | 4.476 | 5.892 | 9.520 | 18.819 | 20.096 | 19.944 | 18.588 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.050 | 4.481 | 9.888 | 15.404 | 15.846 | 13.028 | 7.883 | 5.545 | 13.125 | 8.617 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Teobiomed Srl